A July 2021 study from Brigham and Women's Hospital and elsewhere said
"This meta-analysis provides reassurance about the role of omega-3 fatty acids, specifically prescription EPA”
It should encourage investigators to explore further the cardiovascular effects of EPA across different clinical settings."